Key Highlights: PRA’s partnership with Vineti will optimize clinical trial delivery, clinical study operations and data management, and commercialization readiness...

RALEIGH, NC and SAN FRANCISCO, CA, June 15, 2021 — PRA Health Sciences and Vineti, Inc., today announced a new...

Platform integration will provide therapy developers with full end-to-end visibility, control, and insights into manufacturing and supply chain LONDON and...

New PTM Essentials™ solution draws on Vineti’s industry-leading Personalized Therapy Management® (PTM) software platform to deliver breakthrough speed and simplicity for advanced...

Advanced therapies emerge from advanced science — and must overcome the operational complexity inherent in their patient-centric paradigm when they...

Advanced therapies emerge from advanced science — and must overcome the operational complexity inherent in their patient-centric paradigm when they...

Today, Vineti released an announcement about new industry collaboration around our proposal for a new patient ID for cell and gene therapies....

A look at 2020 and the coming rebound, by the numbers Even before the unpredictable year that was 2020, one...

Introducing new Vineti PTM^® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require...

In advanced therapies, little labels — the in-process labels on bags of cells and final drug products — can sometimes...

A Vineti technology perspective from Chief Technology Officer Phil Calvin Phil Calvin, Vineti’s Chief Technology Officer, is a long-time leader...

A Vineti technology perspective from Chief Commercial Officer Joe DePinto Joe DePinto, Vineti’s Chief Commercial Officer, is a long-time leader...